In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines

Author(s): Manju Sharma, James B. Hudson, Hans Adomat, Emma Guns, Michael E. Cox

Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, Canada. The Vancouver Prostate Centre, 2660 Oak St. Jack Bell Research Centre, Vancouver, Canada. The Vancouver Prostate Centre, 2660 Oak St. Jack Bell Research Centre, Vancouver, Canada Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Subject: Cancer View the study

Abstract:

Cannabinoids, the active components of Cannabis sativa Linnaeus, have received renewed interest in recent years due to their diverse pharmacologic activities such as cell growth inhibition, anti-inflammatory effects and tumor regression, but their use in chemotherapy is limited by their psychotropic activity. To date, cannabinoids have been successfully used in the treatment of nausea and vomiting, two common side effects that accompany chemotherapy in cancer patients. Most non-THC plant cannabinoids e.g. cannabidiol and cannabigerol, seem to be devoid of psychotropic properties.

Source: Pharmacology & Pharmacy
Share Tweet

More medical studies related to Cancer:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

ссылка e-kirpich.kiev.ua

подробнее sledoc.com.ua

подробнее